HK1250483A1 - 用於脂肪減少的美容方法和治療用途 - Google Patents

用於脂肪減少的美容方法和治療用途

Info

Publication number
HK1250483A1
HK1250483A1 HK18109898.4A HK18109898A HK1250483A1 HK 1250483 A1 HK1250483 A1 HK 1250483A1 HK 18109898 A HK18109898 A HK 18109898A HK 1250483 A1 HK1250483 A1 HK 1250483A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic use
cosmetic method
fat reduction
fat
reduction
Prior art date
Application number
HK18109898.4A
Other languages
English (en)
Inventor
Neil J Poloso
Jenny W Wang
David F Woodward
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HK1250483A1 publication Critical patent/HK1250483A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • A61Q7/02Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK18109898.4A 2015-04-30 2018-08-01 用於脂肪減少的美容方法和治療用途 HK1250483A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562154926P 2015-04-30 2015-04-30
PCT/US2016/030251 WO2016176640A1 (en) 2015-04-30 2016-04-29 Cosmetic method and therapeutic use for fat reduction

Publications (1)

Publication Number Publication Date
HK1250483A1 true HK1250483A1 (zh) 2018-12-21

Family

ID=56072424

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109898.4A HK1250483A1 (zh) 2015-04-30 2018-08-01 用於脂肪減少的美容方法和治療用途

Country Status (16)

Country Link
US (2) US9795615B2 (zh)
EP (2) EP3721885A1 (zh)
JP (1) JP6796601B2 (zh)
KR (1) KR102159427B1 (zh)
CN (1) CN107660145B (zh)
AU (1) AU2016254208B2 (zh)
BR (1) BR112017023316A2 (zh)
CA (1) CA2983942A1 (zh)
CL (1) CL2017002726A1 (zh)
HK (1) HK1250483A1 (zh)
IL (2) IL255318B (zh)
MX (1) MX2017013819A (zh)
RU (1) RU2017140078A (zh)
SG (1) SG11201708827SA (zh)
UA (1) UA120775C2 (zh)
WO (1) WO2016176640A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169075A1 (en) 2013-04-12 2014-10-16 Allergan, Inc. Sustained release of bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
KR102159427B1 (ko) 2015-04-30 2020-09-24 알러간, 인코포레이티드 지방 감소를 위한 미용적 방법 및 치료적 용도
WO2020181232A1 (en) 2019-03-06 2020-09-10 C4 Therapeutics, Inc. Heterocyclic compounds for medical treatment
US11452703B2 (en) 2020-05-21 2022-09-27 Peregrine Ophthalmic PTE LTD. Methods and compositions for reducing adipocyte numbers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602900B2 (en) * 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6124344A (en) 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
WO1996036599A1 (en) 1995-05-18 1996-11-21 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
US5741810A (en) 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US7666912B2 (en) 2006-03-23 2010-02-23 Massachusetts Eye And Ear Infirmary Compositions and methods for reducing body fat
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
FR2920309B1 (fr) * 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US20130071349A1 (en) 2010-03-02 2013-03-21 Allergan, Inc. Biodegradable polymers for lowering intraocular pressure
AU2014228307A1 (en) 2013-03-15 2015-09-10 Allergan, Inc. Bimatoprost for enhancement of leptin production
WO2014169075A1 (en) 2013-04-12 2014-10-16 Allergan, Inc. Sustained release of bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
NO2753788T3 (zh) * 2013-05-10 2018-06-16
WO2015200425A1 (en) * 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
KR102159427B1 (ko) 2015-04-30 2020-09-24 알러간, 인코포레이티드 지방 감소를 위한 미용적 방법 및 치료적 용도

Also Published As

Publication number Publication date
UA120775C2 (uk) 2020-02-10
US20180071308A1 (en) 2018-03-15
MX2017013819A (es) 2018-02-21
IL255318A0 (en) 2017-12-31
CN107660145B (zh) 2021-04-20
EP3288559A1 (en) 2018-03-07
US10117877B2 (en) 2018-11-06
JP2018514554A (ja) 2018-06-07
CN107660145A (zh) 2018-02-02
KR102159427B1 (ko) 2020-09-24
IL282473A (en) 2021-06-30
US9795615B2 (en) 2017-10-24
IL255318B (en) 2021-05-31
JP6796601B2 (ja) 2020-12-09
CL2017002726A1 (es) 2018-05-04
AU2016254208A1 (en) 2017-11-16
EP3288559B1 (en) 2020-06-24
KR20170141770A (ko) 2017-12-26
SG11201708827SA (en) 2017-11-29
BR112017023316A2 (pt) 2018-08-14
RU2017140078A (ru) 2019-05-30
US20160317550A1 (en) 2016-11-03
EP3721885A1 (en) 2020-10-14
RU2017140078A3 (zh) 2019-08-06
WO2016176640A1 (en) 2016-11-03
CA2983942A1 (en) 2016-11-03
AU2016254208B2 (en) 2021-07-15

Similar Documents

Publication Publication Date Title
IL265590B (en) Formulations and methods for keratin treatment
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
SG11201706767RA (en) Materials and methods for treatment of hemoglobinopathies
PT3518783T (pt) Aparelho para redução de tecido
GB201616070D0 (en) Skin cosmetic
IL282473A (en) A cosmetic method and the use of medicine to reduce fat
PL3285636T3 (pl) Układ foroptera i sposób jego użycia
GB201519200D0 (en) Skin care composition and method thereof
HK1256541A1 (zh) 用於處理皮膚的方法和組合物
GB201508219D0 (en) Skin and muscle stimulation apparatus
HK1259451A1 (zh) 護膚組合物及其方法
GB201611413D0 (en) Method of skin care
HK1247884A1 (zh) 用於皮膚的美容處理的方法
GB201611406D0 (en) Skin care composition and method thereof
EP3342417A4 (en) COMPOSITION FOR BODY SLIMMING AND SKIN CARE AND PREPARATION METHOD THEREOF
GB201600637D0 (en) Therapeutic treatment methods and apparatus for use therein
ZA201802201B (en) Novel formulation and treatment methods
IL255012A0 (en) Preparations and methods for treating skin conditions
GB201611362D0 (en) Skin care composition and method thereof
GB201507487D0 (en) Human skin treatment tools for human skin treatment apparatus and methods
GB201500555D0 (en) Method and device for the treatment of diseases
GB201519207D0 (en) Skin care composition and method thereof
GB201703768D0 (en) Skin treatment methods
GB201703734D0 (en) Skin treatment methods
IL250244A0 (en) Prevention and treatment of inflammatory skin diseases